Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Aerpio Pharmaceuticals Inc Market Cap
The Aerpio Pharmaceuticals Inc (ARPO) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered ARPO. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for ARPO is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned ARPO 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Aerpio Pharmaceuticals Inc to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ARPO. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ARPO.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
HC Wainwright & Co. | Neutral | $1.5 | Maintains | Dec 14, 2020 |
HC Wainwright & Co. | Neutral | $2 | Maintains | Aug 13, 2020 |
HC Wainwright & Co. | Neutral | $1.5 | Maintains | Jun 25, 2020 |
When did it IPO
2017
Staff Count
0
Country
United States
Sector/Industry
/
CEO
Market Cap
$94.8M
In 2023, ARPO generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ARPO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 18 Aug 2021
Sentiment - POSITIVE
Source - PennyStocks
Summary - Investors are currently focused on selecting penny stocks, with specific attention on three notable options highlighted in recent discussions.
Why It Matters - Penny stocks can offer high volatility and potential for significant returns, attracting investor interest as they look for undervalued opportunities in the market.
Fri, 13 Aug 2021
Sentiment - POSITIVE
Source - PennyStocks
Summary - An article discusses potential penny stocks for investment. Investors may consider exploring these options for low-cost investment opportunities.
Why It Matters - Interest in penny stocks can indicate market sentiment, potential for high returns, and increased volatility, which can significantly impact investor strategies and portfolio performance.
Wed, 11 Aug 2021
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO) reported its financial results for Q2 2021 on August 11, 2021, along with a business update.
Why It Matters - Aerpio's financial results and business updates can impact stock performance, indicating company health and future growth potential, directly affecting investor sentiment and decisions.
Sat, 17 Jul 2021
Sentiment - POSITIVE
Source - PennyStocks
Summary - Reopening penny stocks are gaining momentum, with six recommended for investors to watch in July 2021.
Why It Matters - Momentum in reopening penny stocks signals potential growth opportunities as economies recover, attracting speculative investments that could yield high returns.
Sun, 18 Jul 2021
Sentiment - POSITIVE
Source - PennyStocks
Summary - Four penny stocks are highlighted as potential buys for July. Investors may want to consider these options for their portfolios.
Why It Matters - The mention of penny stocks indicates potential high-risk, high-reward investment opportunities, attracting speculative investors seeking quick gains in a volatile market.
Mon, 12 Jul 2021
Sentiment - POSITIVE
Source - PennyStocks
Summary - Biotech penny stocks are currently attracting investor attention, with four specific stocks recommended for watchlists.
Why It Matters - Biotech penny stocks can indicate emerging opportunities and potential high returns, attracting investors looking for growth in a volatile market.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
